Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-16T18:21:55.500Z Has data issue: false hasContentIssue false

Clinical Use of Biomarkers in Suicidal Behaviors

Published online by Cambridge University Press:  23 March 2020

P. Courtet*
Affiliation:
CHU Lapeyronie, Emergencic Psychiatry, Montpellier, France

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The epidemiology, risk factors, and biological basis of suicidal behaviors have been the object of an ever–increasing research in the last three decades. During this period, researchers all over the world have identified potential biomarkers of risk and developed several theories about the mechanisms leading to suicidal behavior. However, the lack of common terminology, instruments, and cooperation has been a major deterrent. Today, the community has established the bases for this collaboration and evidence coming from neuroscientific studies can already be applied to the field of suicidology. We present here a potential semiology based on current evidence coming from biological, clinical, and neuroimaging studies.

Disclosure of interest

The author declares that he has no competing interest.

Type
Symposium: Clinical Management and Treatment of Suicidal Patients
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.